We are live on ! Find out more
VIVS

VivoSim Labs

100 hedge funds and large institutions have $102M invested in VivoSim Labs in 2014 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 29 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.09% more ownership

Funds ownership: 0%0.09% (+0.09%)

3% less repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 29

13% less funds holding

Funds holding: 115100 (-15)

23% less capital invested

Capital invested by funds: $133M → $102M (-$30.6M)

23% less call options, than puts

Call options by funds: $6.96M | Put options by funds: $9.05M

56% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 27

Holders
100
Holders Change
-15
Holders Change %
-13.04%
% of All Funds
2.9%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
28
Reduced
29
Closed
27
Calls
$6.96M
Puts
$9.05M
Net Calls
-$2.09M
Net Calls Change
+$204K
Name Holding Trade Value Shares
Change
Change in
Stake
State Street
1
State Street
Massachusetts
$19.2M +$1.81M +997 +9%
Vanguard Group
2
Vanguard Group
Pennsylvania
$12M +$247K +136 +2%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$10.5M
BFA
4
BlackRock Fund Advisors
California
$9.59M -$272K -150 -2%
Northern Trust
5
Northern Trust
Illinois
$4.65M +$4.13M +2,277 +297%
BIT
6
BlackRock Institutional Trust
California
$4.47M -$228K -126 -4%
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$3.42M +$2.93M +1,614 +260%
Morgan Stanley
8
Morgan Stanley
New York
$3.37M -$393K -217 -9%
CNB
9
City National Bank
California
$3.16M +$227K +125 +6%
U
10
UBS
Switzerland
$2.44M -$2.15M -1,186 -43%
Goldman Sachs
11
Goldman Sachs
New York
$2.38M -$2.94M -1,622 -51%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$2.21M +$239K +132 +10%
GC
13
Guggenheim Capital
Illinois
$2.2M +$131K +72 +5%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$2.17M +$299K +165 +13%
AFG
15
American Financial Group
Ohio
$1.6M
TCIM
16
TIAA CREF Investment Management
New York
$1.45M -$34.4K -19 -2%
BIM
17
BlackRock Investment Management
Delaware
$1.17M +$27.2K +15 +2%
Charles Schwab
18
Charles Schwab
California
$894K -$72.5K -40 -6%
PM
19
Penbrook Management
New York
$789K -$5.44K -3 -0.6%
California State Teachers Retirement System (CalSTRS)
20
California State Teachers Retirement System (CalSTRS)
California
$735K +$10.9K +6 +1%
AFG
21
Albion Financial Group
Utah
$710K -$29K -16 -3%
LPL Financial
22
LPL Financial
California
$651K +$18.1K +10 +2%
MP
23
Mangrove Partners
Connecticut
$637K
TA
24
Teachers Advisors
New York
$560K
Cambridge Investment Research Advisors
25
Cambridge Investment Research Advisors
Iowa
$559K +$663K +366 New

VIVS Hedge Fund Activity: Q3 2014 in Review

100 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q3 2014, worth a combined $102M — down 23% from $133M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of VIVS and 12 opened new positions — a net loss of 15 holders — while 29 trimmed existing stakes and 28 added.

The largest buyer was Northern Trust, adding an estimated $4.13M. The largest seller was Goldman Sachs, cutting an estimated $2.94M.

  • 100 institutional investors held VivoSim Labs (VIVS) as of Q3 2014, down from 115 in Q2 2014.
  • Funds reported $102M of VivoSim Labs stock for Q3 2014, down 23% quarter-over-quarter.
  • 12 funds opened new VivoSim Labs positions in Q3 2014 and 27 closed out, a net change of -15 holders.
  • The largest VivoSim Labs buyer in Q3 2014 was Northern Trust, an estimated $4.13M added.
  • The largest VivoSim Labs seller in Q3 2014 was Goldman Sachs, an estimated $2.94M sold.

Based on aggregated 13F filings for Q3 2014.